Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Longdanhua is a Traditional Tibetan Medicine (TTM) formulation used primarily for the treatment of respiratory conditions such as acute tracheobronchitis and chronic bronchitis. The formula consists of ten botanical ingredients, with *Gentiana algida* (Longdanhua) serving as the principal component. It is traditionally indicated for clearing heat, resolving phlegm, and relieving cough, specifically targeting the 'phlegm-heat obstructing the lung' syndrome. Clinical evaluations, including those sponsored by institutions like The Second Affiliated Hospital of Tianjin University of Chinese Medicine, focus on its efficacy in reducing cough severity and sputum production while maintaining a favorable safety profile. The therapeutic effects are attributed to the synergistic anti-inflammatory, antitussive, and expectorant properties of its constituent herbs, which include *Terminalia chebula* and *Adhatoda vasica*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shiwei Longdanhua.